MaaT Pharma, Clinigen Partner to Commercialize Xervyteg in Europe
July 3, 2025
MaaT Pharma and Clinigen signed exclusive long-term licensing and distribution agreement and commercial supply agreement for Xervyteg (MaaT013), its first in class treatment proposed for patients